Frank C. Eisenschenk

Array ( [id] => 4241196 [patent_doc_number] => 06090930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Recombinant human anti-FB5 antibodies' [patent_app_type] => 1 [patent_app_number] => 9/013872 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9414 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090930.pdf [firstpage_image] =>[orig_patent_app_number] => 013872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936576 [patent_doc_number] => 05871937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/990849 [patent_app_country] => US [patent_app_date] => 1997-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 22477 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871937.pdf [firstpage_image] =>[orig_patent_app_number] => 990849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4066418 [patent_doc_number] => 05866689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Monoclonal antibodies to GP130 protein' [patent_app_type] => 1 [patent_app_number] => 8/794282 [patent_app_country] => US [patent_app_date] => 1997-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3826 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866689.pdf [firstpage_image] =>[orig_patent_app_number] => 794282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883527 [patent_doc_number] => 05833984 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Composition and method for preventing and treating inflammation with Immunoglobulin A' [patent_app_type] => 1 [patent_app_number] => 8/772264 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8590 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833984.pdf [firstpage_image] =>[orig_patent_app_number] => 772264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946726 [patent_doc_number] => 05990296 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Single chain B3 antibody fusion proteins and their uses' [patent_app_type] => 1 [patent_app_number] => 8/759804 [patent_app_country] => US [patent_app_date] => 1996-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 41 [patent_no_of_words] => 28170 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990296.pdf [firstpage_image] =>[orig_patent_app_number] => 759804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810587 [patent_doc_number] => 05854401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Determination of endometrial receptivity toward embryo implantation' [patent_app_type] => 1 [patent_app_number] => 8/706823 [patent_app_country] => US [patent_app_date] => 1996-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 22 [patent_no_of_words] => 6101 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854401.pdf [firstpage_image] =>[orig_patent_app_number] => 706823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3952210 [patent_doc_number] => 05955605 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Biotinidase resistant biotin-DOTA conjugates' [patent_app_type] => 1 [patent_app_number] => 8/695940 [patent_app_country] => US [patent_app_date] => 1996-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 22 [patent_no_of_words] => 43127 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955605.pdf [firstpage_image] =>[orig_patent_app_number] => 695940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810988 [patent_doc_number] => 05811522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Recombinant humanized anti-FB5 antibodies' [patent_app_type] => 1 [patent_app_number] => 8/657012 [patent_app_country] => US [patent_app_date] => 1996-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8331 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811522.pdf [firstpage_image] =>[orig_patent_app_number] => 657012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3856971 [patent_doc_number] => 05795560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Targeting protein-diagnostic/therapeutic agent conjugates having Schiff base linkages' [patent_app_type] => 1 [patent_app_number] => 8/648833 [patent_app_country] => US [patent_app_date] => 1996-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6831 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795560.pdf [firstpage_image] =>[orig_patent_app_number] => 648833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770376 [patent_doc_number] => 05817313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Monoclonal antibodies and conjugates thereof useful for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/629053 [patent_app_country] => US [patent_app_date] => 1996-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5467 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817313.pdf [firstpage_image] =>[orig_patent_app_number] => 629053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636117 [patent_doc_number] => 05631350 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Anti-human influenza virus antibody' [patent_app_type] => 1 [patent_app_number] => 8/630918 [patent_app_country] => US [patent_app_date] => 1996-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22845 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631350.pdf [firstpage_image] =>[orig_patent_app_number] => 630918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994415 [patent_doc_number] => 05892000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples' [patent_app_type] => 1 [patent_app_number] => 8/581724 [patent_app_country] => US [patent_app_date] => 1995-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11696 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892000.pdf [firstpage_image] =>[orig_patent_app_number] => 581724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619393 [patent_doc_number] => 05614408 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Monoclonal antibodies to potato, tomato, and eggplant glycoalkaloids and assays for the same' [patent_app_type] => 1 [patent_app_number] => 8/544748 [patent_app_country] => US [patent_app_date] => 1995-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5108 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614408.pdf [firstpage_image] =>[orig_patent_app_number] => 544748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3616995 [patent_doc_number] => 05641471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Method for preparing .sup.213 Bi for therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/527296 [patent_app_country] => US [patent_app_date] => 1995-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5350 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641471.pdf [firstpage_image] =>[orig_patent_app_number] => 527296 [rel_patent_id] =>[rel_patent_doc_number] =>)